oc osteocalcin intact elisa Search Results


oc osteocalcin intact elisa  (ALPCO)
91
ALPCO oc osteocalcin intact elisa
Oc Osteocalcin Intact Elisa, supplied by ALPCO, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oc+osteocalcin+intact+elisa/Intact+Osteocalcin+ELISA/10__2478_slash_amma___2014___0021-46-25-29
Average 91 stars, based on 1 article reviews
oc osteocalcin intact elisa - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier
osteocalcin  (ALPCO)
93
ALPCO osteocalcin
Baseline characteristics of study cohort un-stratified and stratified by treatment
Osteocalcin, supplied by ALPCO, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oc+osteocalcin+intact+elisa/Osteocalcin+ELISA/pmc05310667-348-11-47
Average 93 stars, based on 1 article reviews
osteocalcin - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
serum intact osteocalcin  (Bio-Rad)
93
Bio-Rad serum intact osteocalcin
Baseline characteristics of study cohort un-stratified and stratified by treatment
Serum Intact Osteocalcin, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oc+osteocalcin+intact+elisa/Liquichek+Cardiac+Markers+Plus+Control+LT/pm17488197-81-0-32
Average 93 stars, based on 1 article reviews
serum intact osteocalcin - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
intact osteocalcin (intact oc; ria kit  (Mitsubishi-Kagaku Foods)
90
Mitsubishi-Kagaku Foods intact osteocalcin (intact oc; ria kit
Baseline characteristics of study cohort un-stratified and stratified by treatment
Intact Osteocalcin (Intact Oc; Ria Kit, supplied by Mitsubishi-Kagaku Foods, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oc+osteocalcin+intact+elisa/intact+osteocalcin++intact+oc++ria+kit/pm11982890-29-38-46
Average 90 stars, based on 1 article reviews
intact osteocalcin (intact oc; ria kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
serum intact osteocalcin two-site human specific elisa  (Erilab Oy)
90
Erilab Oy serum intact osteocalcin two-site human specific elisa
Baseline characteristics of study cohort un-stratified and stratified by treatment
Serum Intact Osteocalcin Two Site Human Specific Elisa, supplied by Erilab Oy, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oc+osteocalcin+intact+elisa/serum+intact+osteocalcin+two+site+human+specific+elisa/10__3109_slash_00365519409095218-991-3-12
Average 90 stars, based on 1 article reviews
serum intact osteocalcin two-site human specific elisa - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Baseline characteristics of study cohort un-stratified and stratified by treatment

Journal: Aging (Albany NY)

Article Title: Melatonin-micronutrients Osteopenia Treatment Study (MOTS): a translational study assessing melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osteopenic women following a one-year double-blind RCT and on osteoblast-osteoclast co-cultures

doi: 10.18632/aging.101158

Figure Lengend Snippet: Baseline characteristics of study cohort un-stratified and stratified by treatment

Article Snippet: Bone formation markers total procollagen type 1 amino-terminal propeptide (P1NP) and osteocalcin (OC; both intact and N-terminal mid-fragments) were measured in the serum samples via ELISA using the human total P1NP ELISA kit for serum (Mybiosource, CA, USA) and osteocalcin (1-43/49) enzyme immunoassay assay kit for serum (ALPCO Diagnostic, NH, USA), respectively, per kit instructions.

Techniques: Fat

Bone formation markers ( A ) total procollagen type 1 amino-terminal propeptide (P1NP) and ( B ) osteocalcin (OC; both intact and N-terminal mid-fragments), serum bone resorption marker ( C ) Collagen Type I C-Telopeptide (CTx) were measured at months 0, 6 and 12. Serum samples were collected from participants (n=11 per group) and bone markers concentrations were measured by sandwich ELISA assay using commercially available specific bone marker kits at all three time points. Each point in the line graph represents the least square mean (± S.E.M.) in the bone markers concentration for placebo (open circle, red) and treatment (closed box, blue). Scatter plots represent the ratio of ( D ) CTx: P1NP and ( E ) CTx: OC for each study subject, respectively, where the solid lines indicate the mean (± S.E.M.) value for each group. * p ≤ 0.05 and ** p ≤0.01 versus placebo at similar time points. Longitudinal analysis for repeated measures using a generalized linear mixed model (GLMM) approach, considering groups and times as fixed effects and subjects nested within the groups as random.

Journal: Aging (Albany NY)

Article Title: Melatonin-micronutrients Osteopenia Treatment Study (MOTS): a translational study assessing melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osteopenic women following a one-year double-blind RCT and on osteoblast-osteoclast co-cultures

doi: 10.18632/aging.101158

Figure Lengend Snippet: Bone formation markers ( A ) total procollagen type 1 amino-terminal propeptide (P1NP) and ( B ) osteocalcin (OC; both intact and N-terminal mid-fragments), serum bone resorption marker ( C ) Collagen Type I C-Telopeptide (CTx) were measured at months 0, 6 and 12. Serum samples were collected from participants (n=11 per group) and bone markers concentrations were measured by sandwich ELISA assay using commercially available specific bone marker kits at all three time points. Each point in the line graph represents the least square mean (± S.E.M.) in the bone markers concentration for placebo (open circle, red) and treatment (closed box, blue). Scatter plots represent the ratio of ( D ) CTx: P1NP and ( E ) CTx: OC for each study subject, respectively, where the solid lines indicate the mean (± S.E.M.) value for each group. * p ≤ 0.05 and ** p ≤0.01 versus placebo at similar time points. Longitudinal analysis for repeated measures using a generalized linear mixed model (GLMM) approach, considering groups and times as fixed effects and subjects nested within the groups as random.

Article Snippet: Bone formation markers total procollagen type 1 amino-terminal propeptide (P1NP) and osteocalcin (OC; both intact and N-terminal mid-fragments) were measured in the serum samples via ELISA using the human total P1NP ELISA kit for serum (Mybiosource, CA, USA) and osteocalcin (1-43/49) enzyme immunoassay assay kit for serum (ALPCO Diagnostic, NH, USA), respectively, per kit instructions.

Techniques: Marker, Sandwich ELISA, Concentration Assay